The board of directors of AstraZeneca Pharma India Limited at its Meeting held on December 14, 2022, approved the Resignation of Mr. Gagandeep Singh Bedi (DIN: 07844333) from the Office of Managing Director of the Company with effect from the closing of business hours on December 31, 2022. Reason for Resignation: Consequent to transfer to a new position within AstraZeneca Group.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6,165 INR | +2.69% | -3.02% | +11.69% |
May. 28 | Astrazeneca Pharma India's Net Profit Rises in Fiscal Q4 | MT |
May. 27 | AstraZeneca Pharma India Limited Announces Resignation of Ankush Nandra as Non-Executive Director | CI |
1st Jan change | Capi. | |
---|---|---|
+11.69% | 1.8B | |
+42.69% | 749B | |
+39.03% | 605B | |
-6.87% | 351B | |
+18.74% | 328B | |
+6.76% | 292B | |
+18.60% | 248B | |
-2.54% | 214B | |
+11.05% | 216B | |
+2.64% | 167B |
- Stock Market
- Equities
- ASTRAZEN Stock
- News AstraZeneca Pharma India Limited
- AstraZeneca Pharma India Limited Announces Resignation of Gagandeep Singh Bedi as Managing Director, Effective December 31, 2022